Uncategorised - European Medical Journal

Innovating the Treatment of Chronic Obstructive Pulmonary Disease Exacerbations: A Phone Telesystem to Increase Action Plan Adherence

Chronic obstructive pulmonary disease (COPD) exacerbations are major contributors to the burden of the disease, reducing patients’ quality of life…

Alternative Exercise and Breathing Interventions in Chronic Obstructive Pulmonary Disease: A Critical Review

Interventions such as exercise training and breathing strategies are components of pulmonary rehabilitation for people with chronic obstructive pulmonary…

Adherence Rate to Inhaled Therapies and Factors Affecting Adherence in Elderly Patients with Chronic Obstructive Lung Diseases

Adherence to treatment is essential in chronic diseases, especially in chronic obstructive lung diseases (COLD). Poor adherence to the treatment regimen…

This October 2018, EMJ Supports...

This October, EMJ has proudly showcased its support for Stoptober and World Psoriasis Day.

European Medical Journal Presents: EMJ Dermatology 6.1

The publication of EMJ Dermatology 6.1 is now available, containing a full review of the 27th European Academy of Dermatology and Venereology (EADV)…

Review of the European Academy of Dermatology and Venerology Congress 2018

Held in the city of Paris, France, on the 12th–16th September 2018, the 27th European Academy of Dermatology and Venereology (EADV) Congress lived up to…

Facial Lesions: A Dermoscopic Interactive Session

The differential diagnosis of pigmented macules on sun-damaged facial skin is one of the most challenging procedures in daily dermatological practice.

PASI 90/100, DLQI 0/1, and IL-17 Receptor/Cytokine: Does it Make a Difference and Are We Ambitious Enough?

The main objectives of the symposium were to review recent evidence on what difference targeting Psoriasis Area Severity Index (PASI) 90 or 100 and…

The Influence of Itch and Pain on Sleep in Atopic Dermatitis Patients

Atopic dermatitis (AD) is a common chronic inflammatory skin disease, with the average prevalence ranging from 2.1–4.9% in the general population.

Navigating the Road to Psoriasis Control in Women: Strategies to Optimise the Reproductive Journey

The importance of discussions around the management of women of childbearing age with psoriasis, an issue that has been largely neglected for many years…